lnfluenced by aur entrepreneurial heritage, Orchis invests from seed and focuses on a limited number of private companies building from the ground up making significant long term operational and financial commitments to those companies. Due to aur intimate industry experience, investment focus is on the Life Sciences (pharma, biotechnology, medtech). Other minor investments are made case by case, often opportunity driven, in the areas of chemicals and mining, new materials and new technologies (nanotechnology, internet-facilitated medical services, health care), among others.

Apart from private companies, Orchis may invest in listed companies active in growth technologies (e.g., robotics, big data) and fast growing regional markets. Orchis is striving for limiting risk and for achieving a balanced portfolio generating sustainable superior return. Extra motivation comes from the translation of innovation into products that serve human living in generał and from the development of new therapeutics that will transform human healthcare in particular.